HUMAN eggs have been fully grown in a laboratory for the first time, in a breakthrough that could lead to improved fertility treatments.

Scientists have grown egg cells, which were removed from ovary tissue at their earliest stage of development, to the point at which they are ready to be fertilised.

The advance could safeguard the fertility of girls with cancer ahead of potentially harmful medical treatment, such as chemotherapy.

Loading article content

Immature eggs recovered from patients’ ovarian tissue could be matured in the lab and stored for later fertilisation.

Read more: Boy, one, has testicle frozen to preserve fertility

Conventionally, cancer patients can have a piece of ovary removed before treatment, but re-implanting this tissue can risk reintroducing cancer.

The study has also given insight into how human eggs develop at various stages, which could aid research into other infertility treatments and regenerative medicine.

Scientists and medical experts worked together to develop suitable substances in which eggs could be grown - known as culture mediums - to support each stage of cell development.

Read more: Edinburgh clinic under fire over 'win a baby' contest

Their findings, using tissue donated by women who were undergoing routine surgery, build on 30 years of research.

In previous studies, scientists had developed mouse eggs to produce live offspring, and had matured human eggs from a relatively late stage of development.

The latest study is the first time a human egg has been developed in the lab from its earliest stage to full maturity.

The study, carried out in collaboration with the Royal Infirmary Edinburgh, The Center for Human Reproduction in New York and the Royal Hospital for Sick Children in Edinburgh, was supported by the Medical Research Council. It was published in Molecular Human Reproduction.

Professor Evelyn Telfer, of the School of Biological Sciences, who led the research, said: “Being able to fully develop human eggs in the lab could widen the scope of available fertility treatments.

“We are now working on optimising the conditions that support egg development in this way and studying how healthy they are. We also hope to find out, subject to regulatory approval, whether they can be fertilised.”

Read more: Four in 10 men in Scotland have fertility problems

It is the latest step forward in fertility preservation from Edinburgh researchers, who have have been at the forefront of the science for decades.

Professors David Baird, Hamish Wallace and Richard Anderson pioneered ovarian cryopreservation in the 1990s. They were the first to show that ovarian tissue obtained via keyhole surgery could be frozen long-term to preserve it fertility and ultimately used to conceive at a later date.

It was a major breakthrough for female survivors of cancer therapy who were facing possible infertility.

The first baby born in the UK as a result of this technique was born in 2016 to a 33-year-old woman from Edinburgh who had had a section of her ovary removed and frozen before treatment for kidney cancer in 2005.

Following chemotherapy, doctors re-implanted the tissue in 2015.

The technique has also been recently shown to work in pre-pubescent girls whose reproductive organs have not fully matured. In 2016, a woman received a transplant of ovarian tissue frozen since she was eight years old, and was able to produce eggs.